FBXW7 and colorectal cancer: FBXW7 is an antagonist to the β-catenin of the WNT signaling [116], and exosomal miR-19b has been reported to target and suppress FBXW7 expression in colorectal cancer by enhancing its stemness and promoting radioresistance (Table S1) [97].